Cost-effectiveness of hypertension therapy according to 2014 guidelines
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:372 |
---|---|
Enthalten in: |
The New England journal of medicine - 372(2015), 5, Seite 2447 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Moran, Andrew E [VerfasserIn] |
---|
BKL: | |
---|---|
Themen: |
Adults |
RVK: |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1968369961 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1968369961 | ||
003 | DE-627 | ||
005 | 20220223153644.0 | ||
007 | tu | ||
008 | 160206s2015 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a PQ20160617 |
035 | |a (DE-627)OLC1968369961 | ||
035 | |a (DE-599)GBVOLC1968369961 | ||
035 | |a (PRQ)gale_infotrac_4037169100 | ||
035 | |a (KEY)0171808820150000372000502447costeffectivenessofhypertensiontherapyaccordingto2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q DNB |
084 | |a XA 10000 |q AVZ |2 rvk | ||
084 | |a 44.60 |2 bkl | ||
084 | |a 44.00 |2 bkl | ||
100 | 1 | |a Moran, Andrew E |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cost-effectiveness of hypertension therapy according to 2014 guidelines |
264 | 1 | |c 2015 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
650 | 4 | |a Medical care, Cost of | |
650 | 4 | |a Health aspects | |
650 | 4 | |a Risk factors | |
650 | 4 | |a Analysis | |
650 | 4 | |a Antihypertensive drugs | |
650 | 4 | |a Care and treatment | |
650 | 4 | |a Dosage and administration | |
650 | 4 | |a Cardiovascular diseases | |
650 | 4 | |a Adults | |
650 | 4 | |a Practice guidelines (Medicine) | |
700 | 1 | |a Odden, Michelle C |4 oth | |
700 | 1 | |a Thanataveerat, Anusorn |4 oth | |
700 | 1 | |a Tzong, Keane Y |4 oth | |
700 | 1 | |a Rasmussen, Petra W |4 oth | |
700 | 1 | |a Guzman, David |4 oth | |
700 | 1 | |a Williams, Lawrence |4 oth | |
700 | 1 | |a Bibbins-Domingo, Kirsten |4 oth | |
700 | 1 | |a Coxson, Pamela G |4 oth | |
700 | 1 | |a Goldman, Lee |4 oth | |
773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d Waltham, Mass. : MMS, 1928 |g 372(2015), 5, Seite 2447 |w (DE-627)129495220 |w (DE-600)207154-X |w (DE-576)014893169 |x 0028-4793 |7 nnns |
773 | 1 | 8 | |g volume:372 |g year:2015 |g number:5 |g pages:2447 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_168 | ||
912 | |a GBV_ILN_183 | ||
912 | |a GBV_ILN_287 | ||
912 | |a GBV_ILN_290 | ||
912 | |a GBV_ILN_2004 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2012 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2219 | ||
912 | |a GBV_ILN_2414 | ||
912 | |a GBV_ILN_2424 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4219 | ||
912 | |a GBV_ILN_4256 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4310 | ||
912 | |a GBV_ILN_4315 | ||
912 | |a GBV_ILN_4320 | ||
912 | |a GBV_ILN_4323 | ||
936 | r | v | |a XA 10000 |
936 | b | k | |a 44.60 |q AVZ |
936 | b | k | |a 44.00 |q AVZ |
951 | |a AR | ||
952 | |d 372 |j 2015 |e 5 |h 2447 |